Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
PHASE2
For advanced unresectable intrahepatic cholangiocarcinoma and gallbladder c...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
A Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin Combined With PD-1 Inhibitor and Radiotherapy as Bladder-preserving Therapy in Patients With Localized HER2-high Expressing Muscle-invasive Bladder Urothelial Carcinoma Following Maximal Transurethral Resection
PHASE2
This is a prospective, open label, multicenter clinical study of vediximab ...
Status
Not Yet Recruiting
Location
Renji Hospital, Shanghai Jiaotong University School of Medecine